Implantable Pulse Generator Market, By Product Type [Implantable Cardiac Pacemakers, Implantable Defibrillators Implants, Implantable Nerve Stimulators (Limb Function Stimulation, Bladder Stimulators, Sphincter Stimulators, Diaphragm Stimulators, and Analgesia), Implantable Infusion Pumps, And Implantable Active Monitoring Devices], By Application (Neurovascular Diseases, Cardiovascular Diseases, Orthopedic, and Others), By End User (Hospitals, Ambulatory Surgical Centers, Home Care Settings, Clinics, and Others), And By Region - Trends, Analysis and Forecast till 2034

Report Code: PMI289419 | Publish Date: May 2024 | No. of Pages: 180

Global Implantable Pulse Generator Market Companies

  • Medtronic Inc.
  • Boston Scientific Corporation
  • Integer Holdings Corporation
  • Synapse Biomedical Inc.
  • Nevro Corp.
  • NeuroSigma, Inc.
  •  CVRx, Inc.
  • BioControl Medical
  •  Cyberonics, Inc.
  • Dextronix Inc.
  • Abbott
  • Zoll Medical Corporation
  •  BIOTRONIK, Inc.
  • Microport Scientific Corporation
  • Cook
  • MEDICO S.R.L.
  • Pacetronix Ltd.
  • Oscor Inc.
  • Osypka Medical GmbH.

Recent News:

  • Inspire Medical System’s IV Implantable Pulse Generator (IPG) which stores therapy settings configured by a physician and delivers mild electrical stimulation to the hypoglossal nerve, controlling the tongue muscles to maintain airway patency during sleep, is a key component of the Inspire Upper Airway Stimulation (UAS) system in July 2024. It works together with outside programmers that allow physicians to set and change therapy parameters, as well as letting the patient control therapy activation and intensity.
  • Medical technology company LivaNova has announced the launch of SenTiva Duo in February 2023, an implantable pulse generator which provides vagus nerve stimulation therapy for patients with drug-resistant epilepsy.